Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocation name updated from Padua to Padova, Italy, 35128. The old Padua listing was removed and the Padova listing added to reflect the local city name.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedExpanded list of study locations with numerous new sites across multiple countries (Spain, Romania, Italy, France, Portugal, Mexico, Brazil, Czechia, Poland, Belgium, Austria, the United States, and more). Several existing sites changed status (Not yet recruiting, Completed) or were withdrawn/removed.SummaryDifference3%

- Check41 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a release note and does not alter the study details.SummaryDifference0.0%

- Check63 days agoChange DetectedMinor version tag update from Revision: v3.4.1 to v3.4.2 with no visible changes to study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedPublications section updated: the OPERA-01 reference now shows the 2026 January issue (Future Oncol. 2026 Jan;22(2):157-166) with online publication on 2025-12-29 and updated DOI, replacing the prior 2025-12-29 ahead-of-print citation; page revision noted as v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check78 days agoChange DetectedAdded a 'Show glossary' toggle and updated page metadata to include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the lowercase labels Last Update Submitted that met QC Criteria and No FEAR Act data to align capitalization.SummaryDifference0.1%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.